The acceptability of the AMBITION-cm treatment regimen for HIV-associated cryptococcal meningitis: Findings from a qualitative methods study of participants and researchers in Botswana and Uganda.

• Main Authors: David S Lawrence (Author), Agnes Ssali (Author), Neo Moshashane (Author), Georgina Nabaggala (Author), Lebogang Maphane (Author), Thomas S Harrison (Author), David B Meya (Author), Joseph N Jarvis (Author), Janet Seeley (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<h4>Background</h4>The AMBITION-cm trial for HIV-associated cryptococcal meningitis demonstrated that a single, high-dose of liposomal amphotericin (AmBisome) plus 14-days of oral flucytosine and fluconazole was non-inferior in terms of all-cause mortality to 7-days of amphotericin B deo...